Accessibility Menu
Arrow-Thin-Down
S&P 500
6,752.29
-1.1%
-78.42
Arrow-Thin-Down
DJI
47,353.82
-1.3%
-600.92
Arrow-Thin-Down
NASDAQ
22,521.62
-1.0%
-227.37
Arrow-Thin-Down
Bitcoin
$68,462.00
-3.6%
-$2,579.27
Arrow-Thin-Down
AMZN
$215.25
-1.7%
-$3.69
Arrow-Thin-Down
GOOG
$299.14
-0.6%
-$1.77
Arrow-Thin-Down
META
$645.85
-2.2%
-$14.72
Arrow-Thin-Down
MSFT
$410.53
-0.0%
-$0.15
Arrow-Thin-Down
NVDA
$181.11
-1.2%
-$2.23
Arrow-Thin-Down
TSLA
$398.81
-1.7%
-$6.74
Most Active StocksDaily Stock GainersDaily Stock Losers

4 Stocks That Actually Increased in 2022 -- And They're Still Worth Buying Now

These all handily outperformed the market last year and could do the same in 2023.

By Matt Frankel, CFP – Jan 7, 2023 at 6:17AM EST

The S&P 500 declined 19% in 2022, its worst performance since 2008. However, not all stocks got crushed. In this video, Matt Frankel, CFP®, discusses four stocks in particular that increased in 2022 and still look very attractive as 2023 gets underway.

**Stock prices as of Jan. 4, 2023. This video was published on Jan. 7, 2023.

Read Next

About the Author

Matt Frankel, CFP
Matt Frankel, CFP, is a contributing Motley Fool stock market analyst and personal finance expert covering financial stocks, REITs, SPACs, and personal finance. Prior to The Motley Fool, Matt taught high school and college mathematics. He holds a bachelor’s degree in physics from the University of South Carolina, a master’s degree in mathematics from Nova Southeastern University, and a graduate certificate in financial planning from Florida State University. He won a SABEW award for coverage of the 2017 Tax Cuts and Jobs Act. He is also regularly interviewed by Cheddar, The National Desk, and other TV networks and publications for his financial, stock market, and investing expertise.
TMFMattFrankel
X@MattFrankelCFP

Matthew Frankel, CFP® has positions in Berkshire Hathaway and Teva Pharmaceutical Industries. The Motley Fool has positions in and recommends Berkshire Hathaway. The Motley Fool recommends T-Mobile US and recommends the following options: long January 2023 $200 calls on Berkshire Hathaway, short January 2023 $200 puts on Berkshire Hathaway, and short January 2023 $265 calls on Berkshire Hathaway. The Motley Fool has a disclosure policy.

Matthew Frankel is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through their link, they will earn some extra money that supports their channel. Their opinions remain their own and are unaffected by The Motley Fool.

Stocks Mentioned

T-Mobile US Stock Quote
T-Mobile US
NASDAQ: TMUS
$221.31
(+0.35%)+$0.77
Berkshire Hathaway Stock Quote
Berkshire Hathaway
NYSE: BRKB
$494.11
(-1.26%)-$6.29
Chevron Stock Quote
Chevron
NYSE: CVX
$189.70
(-0.10%)-$0.20
Teva Pharmaceutical Industries Stock Quote
Teva Pharmaceutical Industries
NYSE: TEVA
$30.88
(-2.76%)-$0.88

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services